| Laurel J Pulsifer, OD | |
|
820 Main Street, Berlin, NH 03570 | |
| (603) 752-3510 | |
| Not Available |
| Full Name | Laurel J Pulsifer |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 820 Main Street, Berlin, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538254024 | NPI | - | NPPES |
| PULS824969 | Other | NH | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 602 (New Hampshire) | Primary |
| Provider Name | Sawyer Optometric Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275037566 PECOS PAC ID: 8426304866 Enrollment ID: O20180627002693 |
News Archive
In a market saturated with energy drinks and shots, entrepreneur Paul Ebrahimian knew he was in for a challenge when he founded RED Light(R). However, he had the recipe for a great-tasting beverage, a smart business plan in place and the marketing vision to position RED Light as THE drink of choice-not just for energy, but also as an elixir.
If you've got a plan offered on the federal health law's insurance marketplace and you're looking for a therapist, you may have to look really hard: The average provider network includes only 11 percent of all the mental health care providers in a given market, according to a recent study.
SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that a journal article titled Extracorporeal Shock Wave Therapy for Nonunion of the Tibia, was published in the March 2010 issue of the Journal of Orthopedic Trauma.
DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that the National Institutes of Health (NIH) has awarded DOR a Small Business Innovation Research (SBIR) grant to support the conduct of a Phase 1/2 clinical trial evaluating DOR201, a time-release formulation of oral beclomethasone dipropionate (oral BDP), for the prevention of acute radiation enteritis.
They may seem rigid and set in their ways, but your bones are actually under constant construction and deconstruction. They give up their nutrient treasures (calcium) to the body and then rebuild in a constant give-and-take sort of rhythm.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laurel J Pulsifer, OD 820 Main Street, Berlin, NH 03570 Ph: (603) 752-3510 | Laurel J Pulsifer, OD 820 Main Street, Berlin, NH 03570 Ph: (603) 752-3510 |
News Archive
In a market saturated with energy drinks and shots, entrepreneur Paul Ebrahimian knew he was in for a challenge when he founded RED Light(R). However, he had the recipe for a great-tasting beverage, a smart business plan in place and the marketing vision to position RED Light as THE drink of choice-not just for energy, but also as an elixir.
If you've got a plan offered on the federal health law's insurance marketplace and you're looking for a therapist, you may have to look really hard: The average provider network includes only 11 percent of all the mental health care providers in a given market, according to a recent study.
SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that a journal article titled Extracorporeal Shock Wave Therapy for Nonunion of the Tibia, was published in the March 2010 issue of the Journal of Orthopedic Trauma.
DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that the National Institutes of Health (NIH) has awarded DOR a Small Business Innovation Research (SBIR) grant to support the conduct of a Phase 1/2 clinical trial evaluating DOR201, a time-release formulation of oral beclomethasone dipropionate (oral BDP), for the prevention of acute radiation enteritis.
They may seem rigid and set in their ways, but your bones are actually under constant construction and deconstruction. They give up their nutrient treasures (calcium) to the body and then rebuild in a constant give-and-take sort of rhythm.
› Verified 4 days ago
Dr. Leonard S Shaw, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 44 Mason St, Berlin, NH 03570 Phone: 603-752-6211 Fax: 603-752-7645 |